Filler Reversal in Izmir – Hyaluronidase Assessment and Correction

Filler reversal in Izmir, Türkiye

First identify the problem: swelling, aesthetic correction, infection—or emergency?

At Dr. Orhan Demirer’s dermatology practice in Alsancak, hyaluronidase is not treated as a universal “filler eraser.” Urgency, filler material, timing, tissue findings and the desired degree of HA reduction are assessed before a planned procedure.

  • New-treatment swelling separated from true excess volume
  • HA distinguished from hybrid, biostimulatory and permanent materials
  • Vascular emergency separated from infection and elective correction
  • Selective reduction discussed without promising millimetric precision
Patient concerned about the appearance of a previous facial filler
Illustrative image. A photograph cannot determine filler material, tissue circulation, infection or the correct dissolving target.
HA is the targetHyaluronidase breaks down hyaluronic acid, not every filler material.
Every lump is not fillerOedema, inflammation, infection and fibrosis need different decisions.
Partial or broaderThe goal is defined first, but perfect microscopic selectivity is not promised.
No fixed timelineVisible change and repeat need vary by product, area and tissue response.
Three different clinical pathways

Elective dissolving, infection and vascular occlusion are not the same protocol

1 · Medical emergency

Circulation, vision or neurological warning

Disproportionate or increasing pain, blanching, mottled grey-blue skin, coolness, visual change or stroke-like symptoms require immediate assessment.

2 · Diagnose first

Infection, inflammation or delayed nodule

Warmth, painful redness, discharge, fever or recurrent swelling may need imaging, sampling, medication or another intervention—not automatic dissolving.

3 · Planned correction

Excess volume, migration, asymmetry or Tyndall

After early oedema settles, confirmed HA-related excess, superficial blue-grey show or selected irregularity may be assessed electively.

If a newly injected area only looks swollen and there is no warning sign, early oedema should not be mistaken for the final result. If pain, colour, vision or neurological symptoms are present, do not “wait for swelling to pass.”

Do not wait for an online reply

Sudden visual, neurological or rapidly changing circulation symptoms are an emergency

Skin and circulation

Increasing or unusual pain, blanching, a net-like purple pattern, grey-blue colour, coolness, delayed capillary refill, blistering or a worsening dusky area.

Eye and nervous system

Sudden blurred, double or lost vision; eye pain; eyelid droop; severe headache; facial, arm or leg weakness; difficulty speaking or confusion.

The priority is preservation of threatened tissue and organ function—not an aesthetic contour. Immediate medical assessment and simultaneous escalation may be required.

Confirm the material first

Which fillers can hyaluronidase reduce?

“Dermal filler” is not one substance. Product name, composition, treatment date and lot sticker help determine whether the enzyme has a valid target.

MaterialExpected response to hyaluronidasePlanning note
Hyaluronic acidMay reduce or dissolve suitable HA when the enzyme reaches the productCross-linking, age, density, amount, layer and contact affect response; one session is not guaranteed
Hybrid HA–CaHAThe HA gel component may respond; CaHA microspheres do notHArmonyCa and similar hybrids are not fully reversible like pure HA
CaHA or PLLAParticles are not directly dissolvedNodules, irregularity or complications require material- and finding-specific management
PMMA, silicone, permanent filler or fatNot dissolved by hyaluronidaseImaging, medical treatment, observation or surgical assessment may be relevant
Unknown old fillerResponse should not be guessedObtain records; examination and selected ultrasound assessment may reduce uncertainty

Using hyaluronidase to dissolve cross-linked aesthetic HA may be off-label depending on the preparation and country. Current Türkiye product information, local regulation and informed consent take priority.

Preparing for assessment

What information should you bring?

Filler placed at another practice can be assessed, but missing records increase uncertainty. Filtered photographs and palpation alone may not identify the product or complication.

Product

Label and treatment details

Bring the product sticker, brand, date, area, amount and name of the treating clinic if available.

Timeline

When did the problem begin?

Same-day pain or colour change, early oedema and a delayed recurrent nodule imply different pathways.

Previous intervention

What has already been tried?

Share earlier hyaluronidase, antibiotics, steroids, massage, ultrasound and any additional filler.

  • Bring unfiltered photographs from before filler and the first treatment days where possible.
  • Report previous hyaluronidase, serious allergy, anaphylaxis and marked bee or wasp reactions.
  • Share medicines, supplements, recent infection, vaccination, dental work, herpes and skin disease.
  • Do not stop prescribed medicines on your own.
A palpable area is not a diagnosis

What can swelling, firmness, a lump or colour change mean?

Oedema, bruising or temporary firmness

Recent injection commonly distorts contour. If there is no emergency sign, an appropriate review interval may be safer than immediate correction.

Contour irregularity or Tyndall effect

Superficial HA can create a blue-grey hue or visible edge. Targeted reduction may be considered after the material is confirmed.

Inflammatory nodule or infection

Red, hot, painful, tender or intermittently swollen tissue can require diagnosis, imaging, sampling or medication before any enzyme.

Non-HA material

CaHA, PLLA, PMMA, silicone or fat does not disappear with repeated hyaluronidase merely because it feels like filler.

Fibrosis, scar or tissue response

Firmness or contour change may persist after HA is reduced if surrounding tissue, capsule or scar contributes.

Blood-flow problem

Severe or increasing pain, blanching, mottling, coolness, grey-blue colour or visual symptoms is not left to a routine cosmetic appointment.

Define the objective before the enzyme

Selective reduction or broader dissolving?

Filler reversal does not always mean removing everything. The plan follows the confirmed problem and the next facial strategy, but tissue spread prevents a promise of microscopic precision.

Selective or staged reduction

A local overflow, superficial irregularity, Tyndall effect or limited asymmetry may be targeted conservatively.

  • Smaller defined objective
  • Possible need for more than one stage
  • Neighbouring HA may also be affected
  • Result judged after swelling settles

Broader dissolving and reassessment

Widespread migration, accumulated multilayer HA, disproportionate volume or old material obstructing a new plan may justify a broader approach.

  • More support volume may be lost
  • Pre-existing hollowing can reappear
  • Temporary contour irregularity may be visible
  • New filler is not automatically placed the same day

Sometimes adding filler makes the face heavier; sometimes dissolving every area is unnecessary. This decision cannot be finalised from a selfie.

Planned aesthetic pathway

How is elective filler reversal planned in Izmir?

The steps below apply to planned aesthetic correction. A circulation, visual or neurological emergency does not wait for this routine sequence.

Exclude emergency

Pain, skin colour, temperature, vision and neurological symptoms are screened first.

Confirm product

Material, date, amount, area and previous interventions are recorded.

Diagnose the tissue finding

Oedema, infection, inflammation, fibrosis, excess HA, migration and anatomy are separated.

Map the target

Superficial product, overflow, asymmetry or the broader HA distribution is documented.

Choose the goal

Selective reduction and broader dissolving are compared with their limits.

Review allergy and medicines

Hyaluronidase history, significant allergies, medicines and current infection are considered.

Treat with emergency readiness

The preparation and clinical plan follow the confirmed HA target; this page does not provide a dose chart.

Reassess after swelling

Remaining HA, contour and any need for a further stage are judged when the tissue is readable.

Hyaluronidase dose is not selected from an internet table. Filler cross-linking, age, layer, amount, area, purpose and response influence medical decisions.

Imaging when it changes the decision

When can ultrasound help?

High-frequency ultrasound can help a suitably trained clinician locate filler, distinguish selected tissue findings and understand the relationship to vessels in some complex cases. It may be useful when the product is deep, old, multilayered, migrated or difficult to identify clinically.

Can help with

Location, depth, spread, selected nodules and targeted management planning.

Cannot guarantee

Exact material identification in every case, complete removal or a complication-free outcome.

Must not delay

Immediate clinical and emergency assessment when circulation, vision or neurological symptoms are present.

Published reviews describe ultrasound-assisted management for selected filler complications: ultrasound-assisted complication management and Doppler ultrasound in vascular complications.

Enzyme activity and visible contour are not identical

When does dissolving become visible, and how many sessions are needed?

The timeline below is illustrative. Injection-related swelling can temporarily hide both reduction and residual filler.

During treatment

Stinging, burning, redness, local swelling or tenderness may occur.

Early period

HA volume may begin to reduce while procedure-related oedema obscures the contour.

After tissues settle

Symmetry, remaining product and whether the selected target was met can be judged more reliably.

If another stage is needed

Residual confirmed HA and the new examination findings guide whether further treatment is appropriate.

One session may be enough in some cases. Dense, older, multilayered or poorly accessible filler may need further treatment. “Every filler completely disappears in 24–48 hours” is not a responsible guarantee.

Before and after planned treatment

Do not make a same-day decision from swelling alone

Individual instructions depend on area, preparation, target and tissue response. The treating physician’s advice takes priority over generic online routines.

Do not aggressively press or massage the area unless specifically instructed. Report worsening warmth, redness, discharge, fever, a new firm area or an unexpected allergic symptom.

  • Bring product, date and previous reversal records.
  • Report allergy, anaphylaxis and significant insect-sting history.
  • Keep entry points clean and follow personal makeup advice.
  • Follow personal instructions for exercise and heat exposure.
  • Do not add filler or more enzyme solely because of early swelling.
  • Seek emergency help for pain, colour, vision or neurological change.
Hyaluronidase is also a medical injection

Expected reactions, important risks and limits

Hyaluronidase is valuable when HA is the confirmed target, but it is not risk-free, perfectly selective or certain to produce an exact cosmetic endpoint.

More common or expected

Stinging, burning, pain, redness, swelling, bruising, tenderness, itching and temporary contour asymmetry may occur. Previous volume loss can become visible when filler support is reduced.

Less common but important

Urticaria, angioedema, severe hypersensitivity or anaphylaxis, infection and greater or smaller reduction than intended may occur. Product labelling warns that injection into or around an infected or acutely inflamed area may spread a localised infection.

Possible severe allergy

Breathing difficulty, throat tightness, widespread hives, tongue or lip swelling, dizziness or fainting after hyaluronidase requires emergency help.

Ongoing filler emergency

Visual, neurological or circulation symptoms remain an emergency even if hyaluronidase has already been given. Do not wait for a routine review.

A planned cosmetic dissolving appointment and time-sensitive vascular-occlusion management have different aims, urgency, dosing logic and escalation pathways.

Content was cross-checked against the CMAC vascular-occlusion guideline, 2024 hyaluronidase review, FDA HYLENEX prescribing information and FDA dermal-filler guidance. A preparation’s aesthetic use may be off-label; Türkiye product information and local emergency pathways take priority.

A common fear

Does hyaluronidase “melt the skin” or permanently collapse the face?

Hyaluronidase acts on hyaluronic acid; it is not injected to dissolve fat, muscle, collagen or elastin. However, the enzyme is not a millimetre-perfect tool that distinguishes injected HA from every molecule of native HA in the local tissue.

When filler volume is reduced, pre-existing bone support, fat loss, laxity and asymmetry may become visible again. Procedure swelling, multilayered old filler and broader-than-expected reduction can also create a temporary “collapsed” or irregular appearance.

Neither a guarantee of permanent damage nor a promise that “nothing can happen” should be made without examination. Unexpected change requires photographs, palpation and selected imaging or follow-up.

The second decision

When can new filler be considered after dissolving?

Same-day refilling is not an automatic choice. Swelling and inflammation should subside, infection should be excluded, the true contour should become readable and the reason the previous result failed should be understood.

Some published guidance suggests waiting at least two weeks after uncomplicated elective dissolving, and longer when swelling or inflammation is significant. The appropriate interval remains individual. Sometimes no refill is needed; sometimes a smaller amount, different product or different support area is selected.

If the earlier problem came from material choice, layer, excessive volume or unrealistic goals, repeating the same plan only recreates the risk. Non-HA or hybrid products must not be presented as fully reversible alternatives.

Scope before price

Filler reversal prices in Izmir

The fee depends on the number of areas, selected preparation, extent and depth of confirmed HA, selective or broader goal, clinical monitoring and possible repeat sessions.

An unknown multilayer filler, a delayed complication and one small planned correction do not have the same scope. Vascular-emergency management is not handled as a routine cosmetic “price procedure”; timely medical care is the priority.

Request a planned assessment

Share the product sticker, date, area, symptoms, prior treatments and unfiltered photographs if available.

Dermatologist Dr Orhan Demirer in his Izmir practice
Dermatologist assessment

Diagnosis before dissolving, reassessment afterwards

Dr. Orhan Demirer is a specialist dermatologist practising in Alsancak, Izmir. He reviews the symptom timeline, material, tissue layer, circulation and infection findings, old photographs and the patient’s next facial plan.

Not every firm area receives enzyme, every asymmetry receives more filler or every face needs complete dissolving. The aim is to identify an emergency without delay and define a controlled, traceable goal in planned cases.

  • Emergency triage before aesthetic planning
  • HA and non-HA material distinction
  • Selective and broader goals discussed openly
  • Photography, product records and review plan
English consultation support

Planning filler correction in Izmir from abroad

Online photographs cannot safely rule out a circulation problem, infection or inflammatory nodule. New or worsening warning symptoms require care where you are, not travel to a routine appointment.

Before travelling

Share product labels, dates, symptoms, medicines, allergy history, previous hyaluronidase and original photographs.

At consultation

Material, urgency, anatomy, selective versus broader reduction and the limitations of hyaluronidase are discussed in English.

After treatment

Allow time for swelling, keep urgent contact information and agree how remaining product and contour will be reassessed.

Do not schedule elective dissolving immediately before a flight or onward travel that would prevent observation or urgent reassessment.

Frequently asked questions

Filler reversal in Izmir: hyaluronidase questions

Can every dermal filler be dissolved with hyaluronidase?

No. Hyaluronidase acts on hyaluronic acid. It does not directly dissolve CaHA, PLLA, PMMA, silicone, fat transfer or other non-HA materials. In a hybrid HA-CaHA filler, only the HA gel component may respond.

How can I know whether my old filler is hyaluronic acid?

The most reliable information is the product label and treatment record. If the brand is unknown, timing, examination and selected complex cases may benefit from ultrasound, but touch alone cannot always identify the material with certainty.

How quickly does filler dissolving work?

Enzymatic activity begins early, but injection-related swelling can hide the visible change. Timing depends on product, amount, layer and treatment area; complete visible correction within a fixed 24 or 48 hours cannot be guaranteed.

Will one hyaluronidase session dissolve all filler?

Sometimes one treatment produces a sufficient reduction. Dense, older, multilayered or poorly accessible HA may require another stage. Complete removal is not always the goal and cannot be guaranteed.

Can only part of the filler be dissolved?

A selective or staged reduction can be planned, but hyaluronidase spreads through tissue and cannot be guaranteed to affect only a millimetre-sized fragment while leaving all neighbouring HA unchanged.

Can lip filler be dissolved?

If the lip product is HA, reduction may be considered for confirmed excess volume, migration, asymmetry or superficial irregularity. New-treatment swelling is separated from true overfilling, and circulation symptoms are not managed as a routine cosmetic appointment.

Can under-eye filler be dissolved?

Selected HA under-eye filler may be reduced when superficial blue-grey colour, persistent oedema, visible product or irregularity is confirmed. The periocular region requires careful review because colour, bags and swelling are not all caused by filler.

Can nose filler be dissolved?

HA nose filler may respond to hyaluronidase, but the nose is a high-risk vascular area. Increasing pain, blanching, grey-blue colour or any visual symptom is an emergency and must not wait for a planned dissolving appointment.

Does hyaluronidase melt skin or permanently collapse the face?

Hyaluronidase targets HA rather than fat, muscle, collagen or elastin. However, it is not perfectly selective for injected HA, and removing filler can reveal previous volume loss or laxity. Swelling and broad reduction may also create temporary contour change.

Can hyaluronidase cause an allergic reaction?

Yes. Urticaria, angioedema and anaphylaxis are uncommon but possible. Previous hyaluronidase exposure, serious allergy, anaphylaxis and marked bee or wasp reactions should be reported before treatment.

Is an allergy skin test always required before hyaluronidase?

No single testing rule fits every preparation and situation, and a negative test cannot remove all hypersensitivity risk. Planned use is decided from the product and allergy history; in a vascular emergency, testing must not inappropriately delay time-sensitive care.

Should a newly injected filler be dissolved immediately?

Not solely because it looks swollen during early recovery. If there is no circulation, visual or neurological warning sign, expected oedema and bruising should be distinguished from true excess. Disproportionate pain, colour or vision change requires immediate assessment.

Does every filler lump need hyaluronidase?

No. A lump may represent oedema, product, fibrosis, inflammation, infection, granuloma or a non-HA material. Redness, warmth, tenderness, discharge, fever or recurrent swelling changes the diagnostic and treatment pathway.

Can HArmonyCa or CaHA filler be completely dissolved?

No. Hyaluronidase does not dissolve CaHA microspheres. In HArmonyCa it may affect the HA gel component, but the CaHA component and related tissue response remain, so the product is not fully reversible.

When is ultrasound useful before dissolving filler?

Ultrasound may help selected complex cases when the product location, layer, vessel relationship or cause of a lump is uncertain. It is not mandatory for every case and must not delay urgent clinical assessment.

When can filler be reinjected after dissolving?

There is no automatic same-day plan. Swelling and inflammation should settle, tissue contour should become readable and the cause of the previous problem should be understood. Some guidance suggests at least two weeks after uncomplicated elective treatment, but many cases need longer.

Which symptoms after filler are an emergency?

Unusual or increasing pain, blanching, mottled or grey-blue skin, coolness, sudden visual change, eye pain, eyelid droop, severe headache, weakness or speech difficulty requires emergency assessment. Do not wait for a message reply or routine appointment.

How much does filler reversal cost in Izmir?

The fee depends on the number of areas, selected preparation, extent and depth of confirmed HA, selective or broader treatment goal, clinical monitoring and possible repeat sessions. Vascular-emergency management is not treated as a routine cosmetic price package.

Correct diagnosis comes before “dissolve it all”

For planned correction, bring the product label, treatment date and symptom history. For circulation, vision or neurological warnings, do not wait for an online answer.